Navigation Links
Ceregene Initiates a New Controlled Phase 2b Trial of CERE-120 for Parkinson's Disease
Date:10/19/2010

SAN DIEGO, Oct. 19 /PRNewswire/ -- Ceregene, Inc., a biopharmaceutical company, announced today that enrollment has begun in a new double-blind sham surgery-controlled Phase 2b study evaluating CERE-120 in Parkinson's disease patients. CERE-120 is a gene therapy product that delivers the neurotrophic factor neurturin to degenerating or dying dopamine neurons. Data from the first Phase 2 clinical trial of CERE-120 are being published later this year in Lancet Neurology (to appear online October 21, 2010).

The launch of Phase 2 follows a fully enrolled Phase 1 portion that demonstrated early safety using an enhanced CERE-120 dosing regimen targeting the substantia nigra and putamen, two brain areas especially affected by Parkinson's disease. This study is enrolling at 11 major medical centers throughout the United States and includes investigators Drs. Mark Stacy and Dennis Turner at Duke University School of Medicine, Drs. Catherine Cho and Ron Alterman at Mount Sinai Medical Center, New York, and Drs. Stewart Factor and Nicholas Boulis at Emory University Hospital, who were all involved in treating the patients in the Phase 1 portion of this study.

Additional clinical sites include Columbia University Medical Center, NYC, NY; Beth Israel Medical Center, NYC, NY; University of Pennsylvania Hospital, Philadelphia, PA; University of Alabama, Birmingham, AL; Rush University Medical Center, Chicago, IL; Baylor College of Medicine, Houston, TX; University of California, San Francisco, CA and Stanford University School of Medicine, Palo Alto, CA.

Details on the clinical study can be found at www.ceregene.com or www.clinicaltrials.gov/ct2/show/NCT00985517.

This Phase 2b clinical study is partially funded by a $2.5M LEAPS (Linked Efforts to Accelerate Parkinson's Solutions) award from The Michael J. Fox Foundation for Parkinson's Re
'/>"/>

SOURCE Ceregene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinsons Disease
2. Max Neeman International Initiates Large Phase IV Trial on Type II Diabetes with 25,000 Subjects Across 1,200 Sites
3. Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa)
4. Echo Therapeutics Initiates Needle-Free Biosensor Program for Continuous Lactate Monitoring
5. LigoCyte Pharmaceuticals Initiates First Clinical Trial for Bivalent Intramuscular Norovirus Vaccine
6. ISTA Pharmaceuticals Initiates Phase 3 Clinical Program for REMURA™ in Dry Eye Disease
7. N30 Pharma Initiates Phase 1 Trials of Novel Reductase Inhibitor
8. Vanda Pharmaceuticals Initiates Phase III Clinical Study Aimed at Resetting the Body Clock
9. Cardioxyl Pharmaceuticals Initiates Dose-Defining Phase IIa Study of Its Lead Candidate, CXL-1020, in Heart Failure Patients
10. Pharmasset Initiates Phase 2b Clinical Trial of PSI-7977 for Chronic Hepatitis C Genotypes 1, 2, and 3
11. BioMarin Initiates Phase 3b Study to Evaluate the Effects of Kuvan on Neurophychiatric Symptoms in Subjects with PKU
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... BAKERSFIELD, Calif. , Sept. 1, 2015 /PRNewswire/ ... Chronic Care Management (CCM) and Drug Adherence m ... monitoring help automate the process of non face-to-face ... "With this new release of our apps, ... care management services along with our ONCHIT certified ...
(Date:9/1/2015)... FELTON, California , September 1, 2015 /PRNewswire/ ... is segmented on the basis of sectors, ... of chronic diseases globally coupled with the increasing ... these diseases are expected to propel the growth ... to manage biological information efficiently is known as ...
(Date:9/1/2015)... 1. September 2015 In nur zwei ... Mitarbeitern hat die SHL Group schnell weltweit 3.000 ... rapides Wachstum auf dem Markt der ... und das Management von SHL wieder. ... ist weltweit führend in Design und Herstellung automatischer ...
Breaking Medicine Technology:SPAC International's Drug Adherence and Chronic Care Management App Now available at Apple App and Google Play stores 2Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 2Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 3Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 4SHL Group erreicht wichtigen Markstein von 3.000 Mitarbeitern 2
... Reportlinker.com announces that a new market research report is available in its catalogue: , ... Relieving Drug Market Analysis 2010-2025 , , , ... , Reports details , ... opportunities lie in this diverse market with high, growing demand worldwide? , , ...
... WESTLAKE VILLAGE, Calif. , May 4 ... provider of specialty physician consultations via telemedicine, announced today ... Organization,s 2010 Innovations in Healthcare ABBY Award.  SOC won ... category for their 24/7 teleneurology service that provides immediate ...
Cached Medicine Technology:Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 2Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 3Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 4Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 5Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 6Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 7Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 8Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 9Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 10Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 11Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 12Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 13Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 14Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 15Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 16Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 17Specialists On Call Wins 2010 Innovations in Healthcare ABBY Award 2
(Date:9/1/2015)... ... September 01, 2015 , ... ... has announced that Edge Information Management has been granted continued accreditation based ... Council (BSCC). , “Achieving and maintaining this accreditation takes the involvement ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... law firms and government entities, announced today that it has hired Scott Sanderson, ... Consultant. In this capacity, Sanderson will be responsible for establishing and managing ...
(Date:9/1/2015)... ... September 01, 2015 , ... WorkCare, ... has joined its medical management team as an Associate Medical Director. , ... and types in the U.S. and abroad. , Dr. Nelson has a ...
(Date:9/1/2015)... ... September 01, 2015 , ... SC&H Group, a leading audit, tax, and consulting ... “Best of the Best” firm in the U.S., as well as being ranked a ... Best” in the U.S., selected exclusively on performance in specific areas of financial and ...
(Date:9/1/2015)... Cincinnati, OH (PRWEB) , ... September 01, 2015 , ... ... Kentucky – has devoted the 10th of its monthly Mercy Health: Helping You Be ... America, affecting one in seven men. , In a concise video on Mercy ...
Breaking Medicine News(10 mins):Health News:Edge Information Management Granted Continued NAPBS Accreditation 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 3Health News:Former NFL Standout Scott Sanderson Joins eDiscovery Leader Discovia 2Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 2Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 3Health News:SC&H Group Receives Multiple Honors from INSIDE Public Accounting 2Health News:New Mercy Health Video Explains Most-Common Cancer Found in Men 2
... Traditional methods for assessing patients after cardiac arrest may ... according to a new study by University of Pittsburgh ... journal Resuscitation . "The care of cardiac ... lead author Jon C. Rittenberger, M.D., M.S., assistant professor ...
... CANADA The rapidly growing polio outbreak in Tajikistan ... other regions in the world, states an editorial ... Association Journal ) www.cmaj.ca . It is imperative ... ensuring high vaccination rates. Polio is a serious ...
... a new use for magnetic levitation, or "maglev," the ... to float above the tracks. In ACS, bi-weekly ... putting maglev to use in an inexpensive sensor for ... and colleagues note that measurements of a substance,s density ...
... at the University of Leicester will review the accuracy of ... to clinical practice as it helps maximise the efficacy of ... are affected every day by the diagnoses made by hospitals ... accurate. Nicola Novielli, a PhD research student in the ...
... 23, 2010) Migraine sufferers who experienced abuse ... cardiovascular (CV) disease including stroke and myocardial infarction (MI) ... American Headache Society,s 52nd Annual Scientific Meeting in Los ... of more than 1,300 headache clinic patients diagnosed with ...
... the most expensive health care system, the United States ... Canada, Germany, the Netherlands, New Zealand, and the United ... quality, efficiency, access to care, equity and the ability ... new Commonwealth Fund report. While there is room for ...
Cached Medicine News:Health News:Traditional neurologic exams inadequate for predicting survival of cardiac arrest patients 2Health News:Polio outbreak in Tajikistan is cause for alarm 2Health News:Migraine sufferers who experienced childhood abuse have greater risk of cardiovascular disease 2Health News:US ranks last among 7 countries on health system performance 2Health News:US ranks last among 7 countries on health system performance 3
... disposable loading unit, the LDS-2™ instrument places two ... the cartridge jaw and the knife blade divides ... instrument is activated by squeezing the instrument's handle ... size of the clip is determined by the ...
The ALLPORT and ALLPORT LS Endoscopic Rotating Multiple Clip Appliers have application for use on tubular structures or vessels. The tissue being ligated should be consistent with the size of the cli...
... LIGACLIP Clip Applier is a reusable instrument ... clips. This instrument is used with LIGACLIP ... either 316L stainless steel or titanium. The ... tubular structures where a nonabsorbable ligating device ...
The Tissue Approximating Forceps are to aid in the approximating of the tissue edges....
Medicine Products: